BG100992A - A ranitidine tablet having a hydroxypropylmethylcellulose containing coating and a method for producing said coating - Google Patents

A ranitidine tablet having a hydroxypropylmethylcellulose containing coating and a method for producing said coating

Info

Publication number
BG100992A
BG100992A BG100992A BG10099296A BG100992A BG 100992 A BG100992 A BG 100992A BG 100992 A BG100992 A BG 100992A BG 10099296 A BG10099296 A BG 10099296A BG 100992 A BG100992 A BG 100992A
Authority
BG
Bulgaria
Prior art keywords
coating
producing
ranitidine
hydroxypropylmethylcellulose
ranitidine tablet
Prior art date
Application number
BG100992A
Other languages
Bulgarian (bg)
English (en)
Inventor
Soren Pedersen
Knud Gebhardt-Hansen
Helle Kann
Original Assignee
A/S Gea Farmaceutisk Fabrik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A/S Gea Farmaceutisk Fabrik filed Critical A/S Gea Farmaceutisk Fabrik
Publication of BG100992A publication Critical patent/BG100992A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG100992A 1994-04-22 1996-11-19 A ranitidine tablet having a hydroxypropylmethylcellulose containing coating and a method for producing said coating BG100992A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK046894A DK171127B1 (da) 1994-04-22 1994-04-22 Ranitidintablet med et hydroxypropylmethylcelluloseholdigt overtræk samt fremgangsmåde til at tilvejebringe dette overtræk
PCT/DK1995/000163 WO1995028918A1 (en) 1994-04-22 1995-04-19 A ranitidine tablet having a hydroxypropylmethylcellulose containing coating and a method for producing said coating

Publications (1)

Publication Number Publication Date
BG100992A true BG100992A (en) 1997-08-29

Family

ID=8093891

Family Applications (1)

Application Number Title Priority Date Filing Date
BG100992A BG100992A (en) 1994-04-22 1996-11-19 A ranitidine tablet having a hydroxypropylmethylcellulose containing coating and a method for producing said coating

Country Status (26)

Country Link
US (1) US5741507A (da)
EP (1) EP0794768A1 (da)
JP (1) JPH09512023A (da)
KR (1) KR970702031A (da)
CN (1) CN1146148A (da)
AU (1) AU690680B2 (da)
BG (1) BG100992A (da)
BR (1) BR9507486A (da)
CA (1) CA2187323A1 (da)
CZ (1) CZ283645B6 (da)
DE (1) DE794768T1 (da)
DK (1) DK171127B1 (da)
EE (1) EE03248B1 (da)
ES (1) ES2106696T1 (da)
FI (1) FI964238A0 (da)
GR (1) GR970300040T1 (da)
HU (1) HUT75962A (da)
IS (1) IS4375A (da)
LV (1) LV11591B (da)
MD (1) MD984B1 (da)
NO (1) NO964198D0 (da)
NZ (1) NZ284792A (da)
PL (1) PL316965A1 (da)
RU (1) RU2117476C1 (da)
SK (1) SK134896A3 (da)
WO (1) WO1995028918A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW464502B (en) * 1996-03-12 2001-11-21 Shiseido Co Ltd W/O type emulsified composition and the method of making the same, and W/O type emulsified cosmetic
US6306164B1 (en) 1997-09-05 2001-10-23 C. R. Bard, Inc. Short body endoprosthesis
RU2154469C2 (ru) * 1998-08-10 2000-08-20 Открытое акционерное общество фармацевтическая фирма "ЗДОРОВЬЕ" Способ получения таблеток ранитидина
IT1311915B1 (it) * 1999-04-12 2002-03-20 Pharmexcel S R L Compressa anidra di cloridrato di ranitidina con rivestimento a doppiostrato e sua composizione.
SE9903879D0 (sv) * 1999-10-28 1999-10-28 Ethical Pharmaceuticals Sweden Multipor food protection
RU2155035C1 (ru) * 2000-02-03 2000-08-27 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая композиция, обладающая противоязвенной активностью, и способ ее получения
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
KR100459770B1 (ko) * 2002-01-29 2004-12-04 전자부품연구원 실리카 미립자가 증착된 웨이퍼의 고밀화 방법
US20050152932A1 (en) * 2003-06-12 2005-07-14 Valery Normand Non-crystalline perfume or flavor delivery system
US7641362B2 (en) * 2007-04-30 2010-01-05 Hewlett-Packard Development Company, L.P. Electronic device lighting system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
US4880636A (en) * 1988-05-13 1989-11-14 Franz Robert M Film coated tablet of ranitidine HCl
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
EP0664701B1 (en) * 1992-10-16 1997-09-10 Glaxo Group Limited Taste-masking compositions of ranitidine

Also Published As

Publication number Publication date
AU690680B2 (en) 1998-04-30
CZ283645B6 (cs) 1998-05-13
ES2106696T1 (es) 1997-11-16
BR9507486A (pt) 1997-08-12
HUT75962A (en) 1997-05-28
FI964238A7 (fi) 1996-10-21
CZ308696A3 (en) 1997-04-16
SK134896A3 (en) 1997-05-07
PL316965A1 (en) 1997-03-03
NO964198L (no) 1996-10-03
NZ284792A (en) 1997-03-24
JPH09512023A (ja) 1997-12-02
DK171127B1 (da) 1996-06-24
WO1995028918A1 (en) 1995-11-02
RU2117476C1 (ru) 1998-08-20
EP0794768A1 (en) 1997-09-17
DK46894A (da) 1995-10-23
FI964238L (fi) 1996-10-21
MD984B1 (ro) 1998-06-30
DE794768T1 (de) 1998-01-15
FI964238A0 (fi) 1996-10-21
CN1146148A (zh) 1997-03-26
EE03248B1 (et) 2000-02-15
US5741507A (en) 1998-04-21
NO964198D0 (no) 1996-10-03
IS4375A (is) 1996-10-07
HU9602689D0 (en) 1996-11-28
AU2343095A (en) 1995-11-16
LV11591A (lv) 1996-12-20
LV11591B (en) 1997-04-20
MX9604858A (es) 1998-05-31
CA2187323A1 (en) 1995-11-02
KR970702031A (ko) 1997-05-13
GR970300040T1 (en) 1997-11-28

Similar Documents

Publication Publication Date Title
KR960016882A (ko) 치주염치료를 위한 서방출형 생분해성 제제
EA200300999A1 (ru) Хронотерапевтические дозированные формы
BG100992A (en) A ranitidine tablet having a hydroxypropylmethylcellulose containing coating and a method for producing said coating
RU2000116633A (ru) Производные имидазола, обладающие ингибирующей активностью в отношении фарнезилтрансферазы, и способ их получения, промежуточные соединения, фармацевтическая композиция
KR927003539A (ko) 2-니트로 이미다졸 유도체, 그의 제조방법 및 이를 유효성분으로 하는 방사선 증감제
NZ298981A (en) Preparation of spray dried erythropoietin
KR970702868A (ko) 폴리피롤카복스아미도 나프탈렌 유도체에 연결함으로써 생유용성을 증진시킨 생물학적 활성 화합물(Increased bioavailability of biologically active compounds by linking to polypyrrole-carboxamidonaphthalene derivatives)
UA66750C2 (en) Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors
BG101901A (bg) 2-метил-тиено-бензодиазепинова формулировка за приемане през устата и метод за нейното получаване
AR048457A2 (es) Proceso para formar una composicion farmaceutica de topiramato
SE8702907D0 (sv) Stable pharmaceutical preparation containing granulocyte colony stimulating factor and process for producing the same
BR9603809A (pt) Composto composição orgânica estável e processo de melhoramento da atividade estabilizadora de um antidergradante
EP0680328A1 (en) KETOCONAZOLE COMPOSITIONS FOR LOCAL USE.
PT561073E (pt) Tratamento da hipertensao ocular com beta-bloqueadores e derivados de acido prostanoico
ES2137549T3 (es) Derivados antifungicos de sordaridina.
RU93005051A (ru) Способ получения катионных кристаллов гр или производных гр, катионные кристаллы человеческого гр или производных человеческого гр, фармацевтические препараты, использование процесса кристаллизации
GEP19971017B (en) Process of preparation of benzocycloalkenyldihydroxyalkanoic acids derivatives
EA199800553A1 (ru) Порошок вспенивателя и способ его получения
RU95112519A (ru) (3,4-ди-фторфенокси)метил оксиран и способ его получения
RU96122652A (ru) Таблетка ранитидина с покрытием, содержащим гидроксипропилметилцеллюлозу, и способ нанесения такого покрытия
ATE162188T1 (de) Herstellung von derivaten von n-acetyl neuraminicsäure
EA199700243A1 (ru) Производное аминотетралина для лечения сердечно-сосудистых заболеваний
DE69113290D1 (de) Herstellungsverfahren einer Impregnierungskathode und mittels eines solchen Verfahrens gewonnene Kathode.
EA199600087A1 (ru) Композиция, обладающая антивирусной активностью, способ ее получения и фармацевтическая композиция на ее основе
BR9606955A (pt) Heterocicloalquenos substituísos